Post by Sartorius

🎙️ "We need to be disruptive. Fifteen to twenty years ago, a client told me: 'There will never be a plastic bag in our facility.' Today, it's the standard." René Fáber, Head of the Bioprocess Solutions Division and member of the Sartorius Executive Board, recently joined the Molecule to Market podcast to discuss the state of our industry and where he thinks it is heading with host Raman Sehgal. In the episode, he talks about his unexpected career path to the Executive Board of Sartorius and outlines a fundamental shift in bioprocessing: the transition from established biologics to advanced therapies such as RNA-based approaches and cell and gene therapies. While these modalities are often still seen as too complex and costly, he draws a clear parallel to the early days of single-use technologies – initially questioned, but ultimately becoming the industry standard once scalability and reliability were demonstrated. No matter how much innovation happens, he believes one principle remains the same: 🗨️ "You never change your focus on customers. If you genuinely focus on them, you are forced to change with time. Their needs evolve, new modalities emerge, technologies advance. And if you want to remain a true partner, you must keep moving, innovating and challenging the status quo." Listen to the full episode: 🎧 Apple: https://ow.ly/fmzq50Ze72u 🎧 Spotify: https://ow.ly/4nJm50Ze72s #SimplifyingProgress

Video Content